Clinical Trial Update: Safety and Antiemetic Efficacy of Akynzeo Plus Dexamethasone During Radiotherapy and Concomitant Weekly Cisplatin [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial update evaluating safety and antiemetic efficacy of Akynzeo with dexamethasone during radiotherapy plus weekly cisplatin in cervical cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• Akynzeo (netupitant/palonosetron)
• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Christina Ruhlmann | Conditions: Chemotherapy-induced Nausea and Vomiting, Adverse Event | Phase 2, Phase 3 | Status: UNKNOWN